Frequently Asked Questions

Introduction to Angel Investing

An angel investor provides capital to early-stage startups in exchange for equity or convertible debt, typically during the Pre-Seed to Series A stages.

Angel investing supports startups in their early stages, offering:

  • Potential for High Returns: Early investments in successful startups can yield substantial gains.
  • Influence: Opportunity to mentor and guide emerging companies.
  • Diversification: Introduce a high-risk, high-reward asset class to your portfolio.

Angel investors utilize personal funds to invest in early-stage startups, usually before VCs enter the picture. VCs invest larger amounts at later stages, backing companies that have already demonstrated traction.

  • Biotechnology & precision medicine
  • Healthcare fintech & insurtech
  • AI-driven diagnostics & digital health
  • Smart medical devices & wearables
  • Innovative care delivery models

Angel investments generally have a time frame of 5-7 years. Exit strategies may include mergers & acquisitions (M&A), secondary sales, IPOs, or buybacks.

SteerX Investment Process

SteerX employs a structured investment process that encompasses expert screening, due diligence, startup evaluation, and investment committee approval prior to funding.

  • Startup Sourcing & Evaluation
  • Due Diligence & Investment Committee Approval
  • Investor Participation & Commitment
  • Legal Documentation & Fund Deployment
  • Active Portfolio Monitoring & Growth Support

SteerX provides curated investment opportunities through briefings, deal memos, and exclusive investor meetings.

Opportunities are highlighted through webinars, reports, and detailed startup presentations, ensuring full transparency.

No. Only select high-potential startups that meet SteerX’s stringent due diligence criteria receive funding.

The minimum investment varies; details will be discussed during consultations.

Investors will receive legal agreements, shareholding confirmations, fund reports, and periodic portfolio updates.

Yes, subject to compliance requirements and fund guidelines.

SteerX upholds strict due diligence, governance, and regulatory compliance. However, it’s important to note that startup investments inherently come with risks.

Yes, investors and network members may refer high-potential healthcare startups for evaluation.

Yes, referrals from existing members are encouraged to help grow the investor network.

SteerX respects confidentiality but typically does not sign NDAs during preliminary discussions. However, detailed investment information is securely shared with serious investors.